
Publikationen von Pavel Sinitcyn
Alle Typen
Zeitschriftenartikel (12)
1.
Zeitschriftenartikel
41, S. 1776 - 1786 (2023)
Global detection of human variants and isoforms by deep proteome sequencing. Nature Biotechnology 2.
Zeitschriftenartikel
14 (1), 5252 (2023)
Deep and fast label-free Dynamic Organellar Mapping. Nature Communications 3.
Zeitschriftenartikel
12, e75191 (2023)
Multi-targeted therapy resistance via drug-induced secretome fucosylation. eLife 4.
Zeitschriftenartikel
40 (4), S. 463 - 481 (2022)
Progress and challenges in mass spectrometry-based analysis of antibody repertoires. Trends in Biotechnology 5.
Zeitschriftenartikel
39, S. 1563 - 1573 (2021)
MaxDIA enables library-based and library-free data-independent acquisition proteomics. Nature Biotechnology 6.
Zeitschriftenartikel
1 (1), S. 207 - 234 (2018)
Computational Methods for Understanding Mass Spectrometry-Based Shotgun Proteomics Data. Annual Review of Biomedical Data Science 7.
Zeitschriftenartikel
7, e37018 (2018)
The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins. eLife 8.
Zeitschriftenartikel
15 (6), S. 401 - 401 (2018)
MaxQuant goes Linux. Nature methods 9.
Zeitschriftenartikel
7, 13404 (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nature Communications 10.
Zeitschriftenartikel
8, 44 (2016)
Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. GENOME MEDICINE 11.
Zeitschriftenartikel
13 (9), S. 731 - 740 (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data. Nature methods 12.
Zeitschriftenartikel
15 (8), S. 1453 - 1456 (2015)
Visualization of LC-MS/MS proteomics data in MaxQuant. PROTEOMICS Meeting Abstract (1)
13.
Meeting Abstract
41 (Suppl. 4), S. 85 - 86. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Wien, 28. September 2018 - 02. Oktober 2018. Karger, Basel (2018)
Spatial and temporal monitoring of neoantigen-specific T cells and T-cell receptors in a melanoma patient with secondary immune resistance to Ipilimumab. In Oncology Research and Treatment,